Ignite Creation Date:
2025-12-24 @ 9:28 PM
Ignite Modification Date:
2026-03-06 @ 9:34 AM
Study NCT ID:
NCT03196232
Status:
COMPLETED
Last Update Posted:
2024-01-23
First Post:
2017-06-20
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Epacadostat and Pembrolizumab in Treating Patients With Metastatic or Unresectable Gastroesophageal Junction or Gastric Cancer
Sponsor:
George Albert Fisher
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
IRB-40823
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |